Skip to content

Implementing Exercise Into Clinical Practice in Breast Cancer Care

Evaluation of a Novel Strategy to Implement Exercise Evidence Into Clinical Practice in Breast Cancer Care: The NEXT-BRCA Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04109274
Acronym
NEXT-BRCA
Enrollment
85
Registered
2019-09-30
Start date
2019-10-03
Completion date
2024-02-29
Last updated
2024-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

exercise, physical activity, self-management

Brief summary

BACKGROUND: One in eight women will develop breast cancer in their lifetime. With improved screening and treatment techniques, more women are surviving breast cancer. However, women live with physical and emotional side effects secondary to treatment for years after cancer treatments have ended. Exercise can help to manage these side effects, however, less than 30% of this population takes part in regular exercise. The objective of this trial is to determine the feasibility and effectiveness of a novel exercise and education program for women with breast cancer during chemotherapy. METHODS: Participants in this study include women with a diagnosis of stage 1 - 3 breast cancer undergoing chemotherapy. Women will be divided into three groups. The first group will include 8 sessions of exercise and self-management education during their chemotherapy treatment. The second group will receive self-management education only, and the third group will receive usual care. Outcomes will be compared between groups at baseline, post-intervention, and at 6- and 12- month follow up. Outcomes to be assessed include exercise level, functional mobility, muscle strength, quality of life, health status, and use of health care services. EXPECTED OUTCOMES: Women with breast cancer are among the least active segment of the Canadian population. It is well known that inactivity can lead to physical and psychological side effects, cancer recurrence, and an increase in comorbid conditions. This proposed project addresses a long-standing need to help women with breast cancer become and stay more active by implementing a novel exercise and education program.

Interventions

BEHAVIORALExercise

Exercise component: Aerobic exercise, using recumbent bikes, delivered within the cancer institution. Participants will take part in up to 30-minutes of moderate intensity (50-70% HRmax or 4-6/10 on Rate of Perceived Exertion scale)6 exercise for eight sessions during chemotherapy. An exercise specialist with experience in cancer rehabilitation will supervise the exercise component.

BEHAVIORALSelf-Management

Eight SM modules will be delivered to participants. They will be viewed on an iPad prior to or after the exercise component. The goal of these modules is to aid participants in developing physical activity goals and action plans to continue with between sessions, with an overarching goal of helping them reach exercise guidelines for cancer survivors and the Canadian Physical Activity Guidelines

Four booster sessions will be provided to participants in this group. These will occur at 2, 4, 6, and 8 months post intervention completion. An assessor trained in behavioural counselling will provide booster sessions by phone and will discuss the individuals physical and emotional condition, current exercise level, accomplishment of previously set goals and action plans, and perceived barriers to participation in exercise. The assessor will use facilitation strategies to aid participants in devising strategies to overcome barriers and set realistic goals and action plans.

Sponsors

Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* community-dwelling * English-speaking women * over 18 years of age * currently undergoing adjuvant or neoadjuvant chemotherapy for Stage 1-3 breast cancer * cleared by their oncologist to participate in moderate intensity aerobic exercise

Exclusion criteria

* self-report any chronic condition, cognitive impairment, or injury that would prevent them from participating independently in moderate intensity exercise

Design outcomes

Primary

MeasureTime frameDescription
Change in baseline physical activity level16-weeks, 6-months, 12-monthsTo be assessed using the Godin Leisure Time Exercise Questionnaire (total score 0-no maximum; higher scores indicating higher levels of physical activity) and activity tracker (Fitbit) data (demonstrating steps/day and total time of moderate levels of physical activity; higher scores indicate higher levels of activity).

Secondary

MeasureTime frameDescription
Change in baseline perception of health status16-weeks, 6-months, 12-monthsMeasured using the EQ-5D-3L a measure of health status (has two systems; a 3 level scale assessing five dimensions of health and a visual analogue scale from 0-10; higher scores indicate higher perceptions of health status)
Change in baseline aerobic capacity16-weeks, 6-months, 12-monthsMeasured using the Six-minute walk test (6MWT) (a performance based measure that assesses total distance walked in six minutes, higher scores indicate higher levels of aerobic capacity)
Change in baseline levels of lower extremity strength16-weeks, 6-months, 12-monthsMeasured using a manual muscle dynamometer (Movements assessed will be isometric hip and knee flexion/extension and ankle plantar flexion/dorsiflexion; higher scores indicate higher levels of lower extremity strength).
Change in patient engagement in health services16-weeks, 6-months, 12-monthsMeasured using the Patient Health Engagement Scale (assesses five domains related to the experiences and preferences of patients for their engagement with their health care treatment; score range from 5-35; higher scores indicate higher levels of patient engagement in health services).
Change in baseline levels of resting BP16-weeks, 6-months, 12-monthsTo measure change in cardiovascular outcomes; Measured with sphygmamometer
Change in baseline resting heart rate16-weeks, 6-months, 12-monthsTo measure change in cardiovascular outcomes; Measured with pulsed oximeter
Change in baseline quality of life16-weeks, 6-months, 12-monthsMeasured using the Functional Assessment of Cancer Therapy-Breast (measure of quality of life in breast cancer survivors; scale range 0-144; higher scores indicate higher levels of quality of life).
Change in level of exercise knowledge16-weeks, 6-months, 12-monthsMeasured using the Theory of Planned Behaviour (TPB) based questionnaire (scale range 7-56; higher scores indicate higher levels of exercise knowledge).

Other

MeasureTime frameDescription
Drop out rate throughout studyAt study completion (2 years)Percentage of participants who drop out from study at any time.
Representativeness of study sampleAt recruitment completion (approximately 1 year).Descriptive characteristics of study samples (in regard to characteristics such as age, stage of cancer, fitness level, socio-economic status, etc.)
Adherence rate to interventionAt intervention completion (Approximately 1.3 years)Percentage of total intervention sessions attended.
Recruitment rateAt recruitment completion (approximately 1 year).Percentage of eligible patients actually enrolled in the study.
Retention rateAt intervention completion (Approximately 1.3 years).Percentage of enrolled patients who complete the intervention.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026